Drug developer ADARx seeks $1.74 billion valuation in US IPO
Direct Source Verification:
This story is aggregated from Reuters (reuters.com). Full reporting rights and copyright belong to the primary publisher.
Drug developer ADARx seeks $1.74 billion valuation in US IPO Reuters
Original Source
https://news.google.com/rss/articles/CBMiygFBVV95cUxOUDdGZzVQcUgxaHgwWVV5Z1h2Z3NrdFZYYjVNdnhxX0tzb0NKUEs0RXZVeEdCMHEybkJvRWNpWllYWEtzcmhlQXVwQzB5MzJfUGppNkR3Snd6cXF6MXk4aUEwQ3JHWlBQY1NTRm9YVmVHeFdQdVF0RmdQNG5tbWZyb1J2cUVFVklrNVVTUmxKWjQxcncxalQyR0ExX0FwQW45S1dZX2FSazhXbnBxaWVHRVlqd3FLYzVWSVYxRHFnZGpWcXBOb1pHYnRR?oc=5
